Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
Kwangsik Nho(Indiana University School of Medicine), Rima Kaddurah‐Daouk(Duke University), Cornelia M. van Duijn(University of Oxford), Shannon L. Risacher(Indiana University School of Medicine), John Q. Trojanowski(University of Pennsylvania), Gregory Louie(Duke University), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Rebecca Baillie(Rosa (United States)), Guoxiang Xie(Ningbo University), Gabi Kastenmüller(Queen Mary University of London), Siamak MahmoudianDehkordi(Duke University), Matthias Arnold(Duke University), Thomas Hankemeier(Centre for Human Drug Research), Wei Jia(Sichuan University), Xianlin Han(The University of Texas at San Antonio Health Science Center), Shahzad Ahmad(University of Veterinary and Animal Sciences), Leslie M. Shaw(California University of Pennsylvania), Michael W. Weiner(University of California, San Francisco), Colette Blach(Duke University), P. Murali Doraiswamy(Alzheimer’s Disease Neuroimaging Initiative), Alexandra Kueider‐Paisley(Duke University)
Cited by 340
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k